LISSETTE LIBBY: Open Payments
NPI 1356910244 · HOLLYWOOD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 31 payments from 13 companies in 2025. Trend: 2023 $3,178 · 2024 $1,159 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $190 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Grifols USA, LLC | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $20 |
Products named: VRAYLAR, TRELEGY ELLIPTA, Prolastin-C Liquid, UBRELVY, VOQUEZNA, AIRSUPRA, NURTEC ODT, TREMFYA.
Industry payments across MD — which companies pay providers there.
